ACE inhibition but not angiotensin II antagonism reduces plasma fibrinogen and insulin resistance in overweight hypertensive patients

Roberto Fogari, Annalisa Zoppi, Pierangelo Lazzari, Paola Preti, Amedeo Mugellini, Luca Corradi, Paola Lusardi

Research output: Contribution to journalArticlepeer-review

Abstract

The aim of this study was to compare the effects of the angiotensin- converting enzyme (ACE) inhibitor perindopril and the angiotensin II antagonist losartan on insulin sensitivity and plasma fibrinogen in overweight hypertensive patients. Twenty-eight overweight mild to moderate [diastolic blood pressure (DBP) >90 and

Original languageEnglish
Pages (from-to)616-620
Number of pages5
JournalJournal of Cardiovascular Pharmacology
Volume32
Issue number4
DOIs
Publication statusPublished - Oct 1998

Keywords

  • Fibrinogen
  • Hypertension
  • Insulin resistance
  • Losartan
  • Perindopril

ASJC Scopus subject areas

  • Pharmacology
  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'ACE inhibition but not angiotensin II antagonism reduces plasma fibrinogen and insulin resistance in overweight hypertensive patients'. Together they form a unique fingerprint.

Cite this